WHO ICTRP trial

Comparison between remifentanyl and dexmedetomidine in patients undergoing…

CTRI/2025/06/088091 · Clinical Trials Registry India (CTRI) · Not Recruiting

Key facts

Trial ID CTRI/2025/06/088091
Public title Comparison between remifentanyl and dexmedetomidine in patients undergoing modified radical mastoidectomy under conscious sedation
Scientific title Comparison of remifentanyl vs dexmedetomidine in patients undergoing Modified Radical Mastoidectomy under Conscious sedation - NIL
Primary sponsor Institute of Medical Sciences, Banaras Hindu University
Registry Clinical Trials Registry India (CTRI)
Recruitment status Not Recruiting
Study type Interventional
Phase Phase 4
Countries India
Conditions Health Condition 1: H60-H95- Diseases of the ear and mastoid process
Interventions Intervention1: Monitored Anesthesia care for Modified Radical Mastoidectomy with Dexmedetomidine: The intervention group receives Dexmedetomidine. An initial intravenous bolus dose of zero point four micrograms per kilogram is given over…
Registration date Feb 6, 2025
Target size 45
Secondary IDs NIL
Registry page ctri.nic.in

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations